Dr. Parisa Shamsesfandabadi | Radiation Oncology | Best Researcher Award
PGY5 Resident, Allegheny Health Network, United States 🧬
Dr. Parisa Shamsesfandabadi 🇺🇸 is a dedicated physician and radiation oncology resident with an exceptional academic and research portfolio. Currently serving as Chief Resident at Allegheny Health Network in Pittsburgh, PA, she is recognized for her contributions to oncology, her innovative research presentations, and her commitment to advancing cancer treatment technologies. With a U.S. citizenship and a background rooted in both Iranian and American institutions, Dr. Shamsesfandabadi exemplifies global excellence in medicine, research, and leadership. 🌎👩⚕️✨
Profile
🎓 Education
Dr. Shamsesfandabadi earned her medical degree from Kashan University of Medical Sciences and Health Services (KaUMS), Iran. She completed her Transitional Year internship at Southern Hills Hospital, Las Vegas, NV, and began her residency in Radiation Oncology at Allegheny Health Network, Pittsburgh, PA, where she now serves as Chief Resident. Her academic journey began at the prestigious Tehran Farzanegan School under NODET (National Organization for Development of Exceptional Talents), showcasing her lifelong pursuit of excellence. 📚🎓
👩🔬 Experience
Dr. Shamsesfandabadi brings a rich blend of clinical, academic, and research experiences. She has served in various positions including Research Associate at the VA Medical Center in Durham, NC, and Visiting Scholar at institutions such as Duke University and UNC Chapel Hill. Her hands-on roles span across radiotherapy, imaging, oncology, and pediatric care, with responsibilities ranging from clinical assistantship to advanced cancer imaging analysis. Her involvement in key committees like the CARROS Quality & Safety Committee and editorial roles with Red Journal and eContour reflect her leadership. 🏥📊
🔬 Research Interest
Her research focuses primarily on radiation oncology innovations, image-guided therapies, prostate and breast cancer treatments, and MR-Linac technologies. She also explores cost-effectiveness in cancer treatment, radiogenomics, and functional imaging. Her contributions have impacted multidisciplinary cancer management, showcasing her dedication to precision medicine and patient-centered care. 🧠🩻💡
🏆 Awards
Dr. Shamsesfandabadi has earned numerous awards and recognitions including the 2023 $25,000 Claude Worthington Benedum Foundation Grant for MR-Linac Sarcoma research. She is a recipient of multiple travel and abstract awards from leading organizations such as ASTRO, ESTRO, ACRO, ABS, and the American Radium Society. Her consistent academic excellence has been acknowledged since her school days, earning gold medals, Olympiad titles, and national recognition for her scientific talent. 🥇📜🏅
📚 Publications
Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC) with SPECT Functional Treatment Planning – Advances in Radiation Oncology, 2023 (Accepted)
Comparison of Collapsed Cone and Monte Carlo Algorithms in Tangential Breast Planning – Journal of Radiotherapy in Practice, April 2023
Radiogenomics of lower-grade glioma: tumor shape and genomics – Journal of Neuro-Oncology, May 2017 | Cited by 125+
Radiogenomic analysis of lower-grade glioma – SPIE Proceedings, March 2017
Comparison of Regular and Probiotic Yogurts in Treatment of Acute Watery Diarrhea in Children – Journal of Probiotics and Health, Feb 2016
🏁 Conclusion
Dr. Parisa Shamsesfandabadi is a highly competitive candidate for the Best Researcher Award. Her academic pedigree, wide-ranging research interests, early career recognitions, and commitment to clinical innovation in radiation oncology make her a standout contender. With continuous growth in independent research and authorship, she is poised to become a leading figure in her field.